Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ampullary Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04907851
What this trial is testing

Assess RXC004 Efficacy in Advanced Solid Tumours After Progression on Standard of Care (SoC) Therapy (PORCUPINE2)

Who this might be right for
Advanced Solid Tumours
Redx Pharma Ltd 45
Not applicableLooking for participantsNCT07744087
What this trial is testing

Modified Single-Incision Plus One-Port Versus Conventional Five-Port Laparoscopic Pancreaticoduodenectomy for Nonpancreatic Periampullary Adenocarcinomas

Who this might be right for
Ampullary CarcinomaDuodenal AdenocarcinomaDistal Cholangiocarcinoma
Nanfang Hospital, Southern Medical University 232
Not applicableUnknownNCT01522573
What this trial is testing

T-EUS for Gastrointestinal Disorders: A Multicenter Registry

Who this might be right for
CholangiocarcinomaPancreatic CancerBile Duct Cancer+11 more
Weill Medical College of Cornell University 1,000
Early research (Phase 1)Study completedNCT02333188
What this trial is testing

Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Adenocarcinoma of Unknown PrimaryAdult CholangiocarcinomaGallbladder Carcinoma+14 more
University of Chicago 50
Large-scale testing (Phase 3)Active Not RecruitingNCT05506943
What this trial is testing

CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)

Who this might be right for
Biliary Tract CancerCholangiocarcinomaGall Bladder Cancer+1 more
Compass Therapeutics 168
Not applicableLooking for participantsNCT06801899
What this trial is testing

ToPanc Trial: Survival After Total Versus Partial Pancreaticoduodenectomy for Adenocarcinoma of the Pancreatic Head, Distal Cholangiocarcinoma, and Ampullary Cancer

Who this might be right for
Pancreatic Cancer
Insel Gruppe AG, University Hospital Bern 170
Testing effectiveness (Phase 2)Looking for participantsNCT05116072
What this trial is testing

Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative Fistula

Who this might be right for
Adenocarcinoma of the PancreasAdenocarcinoma of the DuodenumAmpullary Adenocarcinoma
University Hospital, Lille 36
Not applicableUnknownNCT02238613
What this trial is testing

Radioactive Stents for Treatment of Unresectable Biliary Tract Cancer

Who this might be right for
Intrahepatic CholangiocarcinomaCholangiocarcinoma of the Extrahepatic Bile DuctAmpullary Carcinoma+1 more
307 Hospital of PLA 140
Testing effectiveness (Phase 2)Study completedNCT01208103
What this trial is testing

Bevacizumab, Capecitabine, and Oxaliplatin in Treating Advanced Small Intestinal or Ampulla of Vater Adenocarcinoma

Who this might be right for
Ampulla of Vater AdenocarcinomaSmall Intestinal AdenocarcinomaStage III Ampulla of Vater Cancer AJCC v8+7 more
M.D. Anderson Cancer Center 30
Not applicableUnknownNCT01438385
What this trial is testing

Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders

Who this might be right for
Ampullary CancerDuodenal CancerBile Duct Cancer+20 more
Weill Medical College of Cornell University 12,000
Not applicableLooking for participantsNCT06068023
What this trial is testing

The ADAPTA Study: ADjuvant chemotherAPy After Curative Intent resecTion of Ampullary Cancer.

Who this might be right for
Ampullary Adenocarcinoma
Fondazione Poliambulanza Istituto Ospedaliero 400
Testing effectiveness (Phase 2)Looking for participantsNCT07780838
What this trial is testing

Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or Cholangiocarcinoma

Who this might be right for
Locally Advanced Ampulla of Vater CarcinomaLocally Advanced Biliary Tract CarcinomaLocally Advanced Extrahepatic Cholangiocarcinoma+20 more
Ohio State University Comprehensive Cancer Center 29
Not applicableLooking for participantsNCT05780684
What this trial is testing

Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer

Who this might be right for
Colorectal CancerEsophagus CancerAppendix Cancer+2 more
Dartmouth-Hitchcock Medical Center 36
Large-scale testing (Phase 3)Study completedNCT01926236
What this trial is testing

Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract Cancers

Who this might be right for
Biliary Tract CancerGallbladder CancerCholangiocarcinoma+1 more
The Christie NHS Foundation Trust 162
Testing effectiveness (Phase 2)Ended earlyNCT05251233
What this trial is testing

Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy

Who this might be right for
Pancreatic CancerPancreas CancerAmpullary Cancer+4 more
Washington University School of Medicine 56
Large-scale testing (Phase 3)Ended earlyNCT04163900
What this trial is testing

Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
NuCana plc 773
Testing effectiveness (Phase 2)Looking for participantsNCT06760819
What this trial is testing

Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Who this might be right for
Advanced Solid TumorsHER2 Mutation
Bayer 111
Testing effectiveness (Phase 2)Looking for participantsNCT06128551
What this trial is testing

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)Colorectal CancerPancreatic Ductal Adenocarcinoma
Revolution Medicines, Inc. 534
Testing effectiveness (Phase 2)Looking for participantsNCT07282912
What this trial is testing

Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels

Who this might be right for
Foregut AdenocarcinomaEsophageal AdenocarcinomaGastroesophageal Adenocarcinoma+6 more
Yale University 54
Testing effectiveness (Phase 2)UnknownNCT03139487
What this trial is testing

Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism

Who this might be right for
Cancer-associated ThrombosisEsophageal CancerStomach Cancer+7 more
Asan Medical Center 176
Next Page